🇺🇸 FDA
Pipeline program

ZFN modified T cells

806383

Phase 1 mab completed

Quick answer

ZFN modified T cells for HIV is a Phase 1 program (mab) at SANGAMO THERAPEUTICS, INC with 1 ClinicalTrials.gov record(s).

Program details

Company
SANGAMO THERAPEUTICS, INC
Indication
HIV
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials